Subcutaneous (under the skin) delivery of insulin-like growth factor 1 (IGF-1) does not benefit people with ALS at a dose of 0.5 milligrams per kilogram of body weight, according to a large clinical trial whose results were released today.
Click link above for full article
You can make a tax-deductible donation to ALS research through the Fern Cohen Fund of the ALS Association by clicking the link on the sidebar to the left, which will take you directly to the website, where you can donate online. All the money goes to the ALS Association for research and patient services.
Until 2004, I was an independent and active woman -- a former airline sales exec and then a high school educator. Then my body kept betraying me. I was finally diagnosed with ALS/Lou Gehrig's Disease -- confined to a wheelchair and unable to speak. With life at a slower pace, I learned to live a more conscious and mindful life -- buying, eating and other choices. I listen instead of talking, and I observe instead of running and rushing.
Tuesday, November 25, 2008
Subscribe to: Post Comments (Atom)
Post a Comment